Bharat Immunologicals & Biological Corporation has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 31st January 2020, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st December 2019.
The above information is a part of company’s filings submitted to BSE.